Acquisition by Lance Alstodt of 100 shares of BioRestorative Therapies at 2.99 subject to Rule 16b-3

BRTX Stock  USD 1.48  0.02  1.33%   
Slightly above 58% of BioRestorative Therapies' investor base is looking to short. The analysis of the overall investor sentiment regarding BioRestorative Therapies suggests that many traders are alarmed. BioRestorative Therapies' investing sentiment can be driven by a variety of factors including economic data, BioRestorative Therapies' earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by BioRestorative Therapies Director, Officer President, Ceo, Cob. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
Acquisition of 100 common stock at 2.99 of BioRestorative Therapies by Lance Alstodt on 27th of September 2024. This event was filed by BioRestorative Therapies with SEC on 2022-09-22. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

BioRestorative Therapies' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the BioRestorative Therapies' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

BioRestorative Therapies Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards BioRestorative Therapies can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

BioRestorative Therapies Fundamental Analysis

We analyze BioRestorative Therapies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioRestorative Therapies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioRestorative Therapies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Income

Net Income Comparative Analysis

BioRestorative Therapies is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

BioRestorative Therapies Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BioRestorative Therapies stock to make a market-neutral strategy. Peer analysis of BioRestorative Therapies could also be used in its relative valuation, which is a method of valuing BioRestorative Therapies by comparing valuation metrics with similar companies.

Peers

BioRestorative Therapies Related Equities

PULMPulmatrix   16.69   
0%
100.0%
CADLCandel Therapeutics   7.14   
0%
42.0%
MNPRMonopar Therapeutics   6.43   
0%
38.0%
CVKDCadrenal Therapeutics,   3.21   
0%
19.0%
CANFCan Fite   2.44   
0%
14.0%
ANEBAnebulo Pharmaceuticals   2.14   
0%
12.0%
ACHVAchieve Life   0.22   
0%
1.0%
CAPRCapricor Therapeutics   0.10   
1.0%
0%
SABSSAB Biotherapeutics   0.67   
4.0%
0%
XTLBXTL Biopharmaceutica   1.60   
9.0%
0%
AKTXAkari Therapeutics   1.75   
10.0%
0%
CINGCingulate   3.67   
21.0%
0%
BPTHBio Path   3.75   
22.0%
0%
SLNOSoleno Therapeutics   4.29   
25.0%
0%

Additional Tools for BioRestorative Stock Analysis

When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.